BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.

To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.

To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.

Login Register Subscribe

Bayer settles Roundup cancer suits for up to $10.9B


(Reuters) — Bayer AG agreed to settle U.S. lawsuits claiming that its widely used weedkiller Roundup caused cancer for as much as $10.9 billion after more than a year of talks, resolving litigation that has hit the company's share price.

The German drugs and pesticides maker has come to terms with about 75% of the current Roundup plaintiffs, involving about 125,000 filed and unfiled claims overall, it said in a statement on Wednesday.

The settled cases account for about 95% of those currently set for trial, it added.

"The Roundup settlement is the right action at the right time for Bayer to bring a long period of uncertainty to an end," Bayer Chief Executive Werner Baumann said.

The company added it will make a payment of $8.8-$9.6 billion to resolve the current Roundup litigation — including an allowance expected to cover unresolved claims — and $1.25 billion to support a separate class agreement to address potential future litigation.




Read Next

  • Bayer cools prospect of imminent glyphosate settlement

    (Reuters) — German drugs and pesticides company Bayer AG was at pains on Thursday to quell expectations it was nearing an out-of-court settlement laying to rest claims its glyphosate-based weedkillers cause cancer.